Who founded Step Pharma?

Step Pharma was founded by Alain Fischer in 2014.

Who are Step Pharma's investors?

Step Pharma's investors include Hadean Ventures, Kurma Partners, Bpifrance, Pontifax Venture Capital, Sunstone Capital, V-Bio Ventures.

Where is Step Pharma headquartered?

Step Pharma is headquartered in Saint-Genis-Pouilly, FR.

Step Pharma

Saint-Genis-Pouilly, FR · Founded 2014 · 16 employees on LinkedIn · 8 known investors

Find your way into Step Pharma

Your email: who you already know at Step Pharma, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Step Pharma team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.

Biotech Deep Tech Medical Devices

Founders & leadership

Step Pharma was founded in 2014 by Alain Fischer.

Alain FischerFounding Scientist

Investors · 8

Hadean Ventures✓ confirmed by Step PharmaOslo

How we know: Hadean Ventures's portfolio page · the company's own site · step-ph.com · Not right? Tell us

Kurma Partners✓ confirmed by Step PharmaParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · the company's own site · funding news · step-ph.com · the VCSheet dataset · Not right? Tell us

Bpifrance✓ confirmed by Step PharmaParis, Ile-De-France · $270K

How we know: the company's own site · step-ph.com · Not right? Tell us

Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya · $6.3M – $128M

How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Sunstone Capitallisted by Sunstone CapitalFrederiksberg

How we know: Sunstone Capital's portfolio page · the VCSheet dataset · Not right? Tell us

V-Bio Ventureslisted by V-Bio VenturesGhent · $270K – $2.2M

How we know: funding news · Not right? Tell us

Also in the syndicate · 2

PontifaxSunstone Life Science Ventureslead

Funding

SEC filings, press & company announcements

Undisclosed amountSeries COct 2025
Source ↗
Undisclosed amountseries BMar 2021 · 2 sources
Hadean Ventures (lead), Sunstone Life Science Ventures (lead), Bpifrance, Kurma Partners, Pontifax
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Step Pharma announces completion of €38 million Series C financing - BioSpacebiospace.com · Oct 2025

About Us - Step Pharmastep-ph.com · Jul 2022

Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies - Step Pharmastep-ph.com · Mar 2021

Frequently asked questions

What does Step Pharma do?: Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
Who founded Step Pharma?: Step Pharma was founded by Alain Fischer in 2014.
Who are Step Pharma's investors?: Step Pharma's investors include Hadean Ventures, Kurma Partners, Bpifrance, Pontifax Venture Capital, Sunstone Capital, V-Bio Ventures.
Where is Step Pharma headquartered?: Step Pharma is headquartered in Saint-Genis-Pouilly, FR.